ACUSENSUS LIMITED (ACE)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

ACE - ACUSENSUS LIMITED

FNArena Sector : Transportation & Logistics
Year End: July
GICS Industry Group : Software & Services
Debt/EBITDA: 0.38
Index:

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.575

22 Jul
2024

0.000

OPEN

$0.58

0.000

HIGH

$0.58

28

LOW

$0.58

OTHER COMPANIES IN THE SAME SECTOR
AIZ . AQZ . AVD . AZJ . BXB . CLX . ERD . KLS . KSC . LAU . NTD . QAN . QUB . SLH . SPZ . SST . THL . WTC . Z2U .
FNARENA'S MARKET CONSENSUS FORECASTS

- No Record -

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 202120222023
EPS Basic xxxxxx0.0
DPS All xxxxxx0.0
Sales/Revenue xxxxxx42.0 M
Book Value Per Share xxxxxx28.5
Net Operating Cash Flow xxxxxx4.3 M
Net Profit Margin xxxxxx0.13 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202120222023
Return on Capital Employed xxxxxx0.21 %
Return on Invested Capital xxxxxx0.20 %
Return on Assets xxxxxx0.15 %
Return on Equity xxxxxx0.21 %
Return on Total Capital xxxxxx3.53 %
Free Cash Flow ex dividends xxxxxx0.3 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202120222023
Short-Term Debt xxxxxx1 M
Long Term Debt xxxxxx1 M
Total Debt xxxxxx2 M
Goodwill - Gross xxxxxx-
Cash & Equivalents - Generic xxxxxx25 M
Price To Book Value xxxxxx2.24

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202120222023
Capex xxxxxx5.4 M
Capex % of Sales xxxxxx12.80 %
Cost of Goods Sold xxxxxx37 M
Selling, General & Admin. Exp & Other xxxxxx4 M
Research & Development xxxxxx-
Investments - Total xxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

0
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

2

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Wilsons

xx/xx/xxxx

-1

xx xxxxxx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Canaccord Genuity

05/03/2024

1

Buy

$1.30

126.09%

Acusensus has guided to FY24 revenue of $49-51m, and EBITDA of $4-5m, both slightly ahead of Canaccord Genuity's estimates. The business is in the early stages of its global expansion, leveraging patented technology in order to capture a $1.8bn market opportunity.

While slow to be awarded, government contracts are expected to be delivered in the next six months across three markets - UK, Netherlands, US. New contracts are also expected in Australia which will aid FY25 revenues.

The broker assesses there are few ASX-listed stocks exposed to the AI evolution and this undervalues the existing opportunity and the strength of the company's position. Buy rating. Target rises to $1.30 from $1.10.

FORECAST
Canaccord Genuity forecasts a full year FY24 dividend of 0.00 cents and EPS of minus -0.20 cents.
Canaccord Genuity forecasts a full year FY25 dividend of 0.00 cents and EPS of 0.20 cents.

ACE STOCK CHART